These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18413130)

  • 1. Cellular pathogenesis in prion diseases.
    Crozet C; Beranger F; Lehmann S
    Vet Res; 2008; 39(4):44. PubMed ID: 18413130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
    Kourie JI
    Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
    Jeffrey M; McGovern G; Sisó S; González L
    Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F; Lehmann S; Maridonneau-Parini I
    Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
    FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A; Wu G; Onodera T; Ikuta K
    Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the natural variability of prion diseases.
    Geissen M; Krasemann S; Matschke J; Glatzel M
    Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion proteins: physiological functions and role in neurological disorders.
    Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
    J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient inhibition of prion replication by PrP-Fc(2) suggests that the prion is a PrP(Sc) oligomer.
    Masel J; Genoud N; Aguzzi A
    J Mol Biol; 2005 Feb; 345(5):1243-51. PubMed ID: 15644218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of prion diseases.
    Unterberger U; Voigtländer T; Budka H
    Acta Neuropathol; 2005 Jan; 109(1):32-48. PubMed ID: 15645262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions and peripheral nerves: a deadly rendezvous.
    Heikenwalder M; Julius C; Aguzzi A
    J Neurosci Res; 2007 Sep; 85(12):2714-25. PubMed ID: 17393538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
    Vella LJ; Hill AF
    Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.